[Airplane travels can induce headache].

Area of Science:

• Neurology
• Aerospace Medicine
• Pharmacology

Background:

• Airplane headache is a prevalent condition affecting approximately 100 million air travelers annually.
• The pathophysiology is hypothesized to involve sinus tissue inflammation due to cabin pressure fluctuations during flight.
• This inflammation may trigger elevated prostaglandin E2 levels and cerebral artery vasodilation, contributing to headache onset.

Purpose of the Study:

• To explore the underlying mechanisms of airplane headache.
• To identify potential therapeutic targets for preventing or treating airplane headache.
• To review current evidence for future drug development.

Main Methods:

• Review of existing literature on airplane headache pathophysiology.
• Analysis of the role of cabin pressure changes in sinus inflammation.
• Examination of prostaglandin E2 pathways and cerebral artery vasodilation.

Main Results:

• Cabin pressure changes are implicated in sinus tissue inflammation.
• Elevated prostaglandin E2 levels and cerebral artery vasodilation are key factors in airplane headache.
• Current understanding suggests potential for pharmacological interventions.

Conclusions:

• Airplane headache is linked to pressure-induced sinus inflammation and subsequent biochemical changes.
• Targeting prostaglandin E2 reduction or vasodilation prevention offers promising avenues for treatment.
• Further research into novel drug development is warranted for effective airplane headache management.